RA
SONM icon

Royce & Associates’s DNA X Inc SONM Stock Holding History

Royce & Associates’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5
Closed -$31K – 1191
2019
Q4 		$31K Buy
+5
New +$24.7K ﹤0.01% 1084

Other funds holding SONM

NC
Nokomis Capital Dallas, Texas $290M AUM 55.12% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return

Royce & Associates's SONM Position: Q1 2020 in Review

Royce & Associates sold out of DNA X Inc (SONM) in Q1 2020, closing a stake of 5 shares — an estimated $31K sold.

Royce & Associates first reported a position in SONM in Q4 2019 and held it in 1 quarter. The position peaked at $31K in Q4 2019. 37 funds tracked by Wall St. Rank hold SONM as of Q1 2020.

  • Royce & Associates reported no remaining DNA X Inc position as of Q1 2020 after selling out during the quarter.
  • Royce & Associates sold 5 DNA X Inc shares in Q1 2020, an estimated $31K.
  • Royce & Associates first reported a position in DNA X Inc in Q4 2019 and held it in 1 quarter.
  • Royce & Associates's DNA X Inc position peaked at $31K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2020.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.